Covered recipient · General Payments record
HEATHER R VENEMA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,969.29
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,273.49 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $143.62 | 7 |
| Merck Sharp & Dohme Corporation | $116.28 | 4 |
| Lilly USA, LLC | $107.29 | 4 |
| Daiichi Sankyo Inc. | $84.64 | 3 |
| PFIZER INC. | $68.11 | 3 |
| ABBVIE INC. | $56.75 | 2 |
| Exelixis Inc. | $56.75 | 2 |
| Astellas Pharma US Inc | $56.49 | 2 |
| Acerta Pharma LLC | $51.05 | 2 |
| Rigel Pharmaceuticals, Inc. | $50.72 | 2 |
| Genentech USA, Inc. | $47.24 | 2 |
| Janssen Biotech, Inc. | $43.25 | 2 |
| E.R. Squibb & Sons, L.L.C. | $36.42 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $30.37 | 1 |
| Pharmacosmos Therapeutics Inc. | $29.79 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $28.68 | 1 |
| Incyte Corporation | $27.46 | 1 |
| Genmab U.S., Inc. | $27.46 | 1 |
| PharmaEssentia USA Corporation | $25.91 | 1 |
| EMD Serono, Inc. | $24.37 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.78 | 1 |
| Gilead Sciences, Inc. | $22.72 | 1 |
| TAIHO ONCOLOGY, INC. | $22.02 | 1 |
| Adaptive Biotechnologies Corporation | $21.71 | 1 |
| Stemline Therapeutics Inc. | $21.35 | 1 |
| MorphoSys, US Inc. | $20.72 | 1 |
| Celgene Corporation | $14.89 | 1 |
| SOBI, INC | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.